SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The primate lentivirus auxiliary protein Vpx counteracts an unknown restriction factor that renders human dendritic and myeloid cells largely refractory to HIV-1 infection. Here we identify SAMHD1 as this restriction factor. SAMHD1 is a protein involved in Aicardi-Goutières syndrome, a genetic encephalopathy with symptoms mimicking congenital viral infection, that has been proposed to act as a negative regulator of the interferon response. We show that Vpx induces proteasomal degradation of SAMHD1. Silencing of SAMHD1 in non-permissive cell lines alleviates HIV-1 restriction and is associated with a significant accumulation of viral DNA in infected cells. Concurrently, overexpression of SAMHD1 in sensitive cells inhibits HIV-1 infection. The putative phosphohydrolase activity of SAMHD1 is probably required for HIV-1 restriction. Vpx-mediated relief of restriction is abolished in SAMHD1-negative cells. Finally, silencing of SAMHD1 markedly increases the susceptibility of monocytic-derived dendritic cells to infection. Our results demonstrate that SAMHD1 is an antiretroviral protein expressed in cells of the myeloid lineage that inhibits an early step of the viral life cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, sterile alpha motif and HD domain 1 (SAMHD1) inhibits reverse transcription by depleting the cellular pool of deoxynucleotide triphosphates [63,64]”
From HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This approach was necessary because PU.1 is the master transcriptional regulator necessary for macrophage differentiation and silencing PU.1 prior to infection results in a change in the cellular phenotype that causes resistance to HIV infection72,73.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [72]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Neil, S. J. D., Zang, T., & Bieniasz, P. D. (2008) · Nature · doi:10.1038/nature06553 · Cited by 1,902
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Rice, G. I., Bond, J., Asipu, A., Brunette, R. L., Manfield, I. W., Carr, I. M., Fuller, J. C., Jackson, R. M., Lamb, T., Briggs, T. A., et al. (2009) · Nature Genetics · doi:10.1038/ng.373 · Cited by 689
A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells
Manel, N., Hogstad, B., Wang, Y., Levy, D. E., Unutmaz, D., & Littman, D. R. (2010) · Nature · doi:10.1038/nature09337 · Cited by 427
Sobhian, B., Laguette, N., Yatim, A., Nakamura, M., Levy, Y., Kiernan, R., & Benkirane, M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.04.012 · Cited by 381
Self-citationBlanchet, F. P., Moris, A., Nikolic, D. S., Lehmann, M., Cardinaud, S., Stalder, R., Garcia, E., Dinkins, C., Leuba, F., Wu, L., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.04.011 · Cited by 295
Self-citationImmunoaffinity Purification of Mammalian Protein Complexes
Nakatani, Y., & Ogryzko, V. (2003) · Methods in Enzymology · doi:10.1016/s0076-6879(03)70037-8 · Cited by 283
DCs and NK cells: critical effectors in the immune response to HIV-1
Altfeld, M., Fadda, L., Frleta, D., & Bhardwaj, N. (2011) · Nature Reviews Immunology · doi:10.1038/nri2935 · Cited by 216
Srivastava, S., Swanson, S. K., Manel, N., Florens, L., Washburn, M. P., & Skowronski, J. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000059 · Cited by 209
Cited by
Items 901–1,000 of 1,001
The SAMHD1-MX2 axis restricts HIV-1 infection at postviral DNA synthesis
Guo, H., Yang, W., Li, H., Yang, J., Huang, Y., Tang, Y., Wang, S., Ni, F., Yang, W., Yu, X., et al. (2024) · mBio · doi:10.1128/mbio.01363-24 · Cited by 14
Rashid, F., Zaongo, S. D., Iqbal, H., Harypursat, V., Song, F., & Chen, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1390650 · Cited by 14
Genotoxic consequences of viral infections
Szewczyk-Roszczenko, O. K., Roszczenko, P., Vassetzky, Y. S., & Sjakste, N. (2025) · npj Viruses · doi:10.1038/s44298-024-00087-5 · Cited by 14
Restricted Access to Myeloid Cells Explained
Planelles, V. (2011) · Viruses · doi:10.3390/v3091624 · Cited by 14
“the sterile alpha motif (SAM) and HD domain-containing protein-1 protein (SAMHD1) [29,30].”
BackgroundInfluentialMlčochová, P., Watters, S. A., Towers, G. J., Noursadeghi, M., & Gupta, R. K. (2014) · Retrovirology · doi:10.1186/1742-4690-11-25 · Cited by 13
“This mammalian protein is the target of the lentiviral accessory gene vpx, found in HIV-2/SIVsm lineage viruses, but not in the SIVgsn lineage or HIV-1/SIVcpz [24].”
BackgroundSelective use of primate CD4 receptors by HIV-1
Warren, C. J., Meyerson, N. R., Dirasantha, O., Feldman, E. R., Wilkerson, G. K., & Sawyer, S. L. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000304 · Cited by 14
Rabezanahary, H., Clain, J. A., Racine, G., Andreani, G., Benmadid-Laktout, G., Borde, C., Mammano, F., Mésplède, T., Ancuța, P., Zghidi‐Abouzid, O., et al. (2020) · Journal of Virology · doi:10.1128/jvi.01478-20 · Cited by 14
“Whereas HIV-1 expresses the Vpr protein, SIVmac expresses the Vpx protein, which has been shown to facilitate viral infectivity by counteracting SAMHD1 activity in myeloid cells in vitro (88, 89).”
BackgroundKubo, Y., Yasui, K., Izumida, M., Hayashi, H., & Matsuyama, T. (2022) · Cells · doi:10.3390/cells11142240 · Cited by 13
“The results showed that mRNA levels of already known host restriction factors which inhibit HIV-1 infection, TRIM5α [19], MX2 [6], SAMHD1 [20], SERINC3 [21], SERINC5 [21,22], IFITM2 [8], IFITM3 [8], ApoE [23], and PSGL-1 [24] were not significantly elevated by γ-IFN (Table 1).”
BackgroundBowen, N. E., Oo, A., & Kim, B. (2022) · Viruses · doi:10.3390/v14081622 · Cited by 14
“In this review, we explained that the low-dNTP-pool environments of non-dividing target cells, such as macrophages, are established by the host lentivirus restriction factor, SAMHD1 [9,12,79,80].”
BackgroundEspada, C. E., Sari, L., Cahill, M. P., Yang, H., Phillips, S. L., Martinez, N., Kenney, A. D., Yount, J. S., Xiong, Y., Lin, M. M., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104925 · Cited by 15
Tilton, C. A., Tabler, C. O., Lucera, M. B., Marek, S. L., Haqqani, A. A., & Tilton, J. C. (2013) · Journal of Virological Methods · doi:10.1016/j.jviromet.2013.08.029 · Cited by 14
“, 2003), and antiviral restriction factors such as SAMHD1 (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundInfluentialSouza, T. M. L., Temerozo, J. R., Giestal‐de‐Araujo, E., & Bou‐Habib, D. C. (2014) · NeuroImmunoModulation · doi:10.1159/000357434 · Cited by 13
The Evolution of Resistance to Simian Immunodeficiency Virus (SIV): A Review
Locatelli, S., McKean, K. A., Clee, P. R. S., & Gonder, M. K. (2014) · International Journal of Primatology · doi:10.1007/s10764-014-9763-7 · Cited by 17
“2008); and sterile α motif and HD domain 1 (SAMHD1), the most recently discovered restriction factor, highly expressed and functional in myeloid cells (Hrecka et al. 2011; Laguette et al. 2011).”
BackgroundLi, D., Schlaepfer, E., Audigé, A., Rochat, M.-A., Ivic, S., Knowlton, C., Kim, B., Keppler, O. T., & Speck, R. F. (2015) · Stem Cell Research · doi:10.1016/j.scr.2015.06.012 · Cited by 14
“The sterile alpha motif (SAM) domain and HD domain-containing protein 1 (SAMHD1) were identified as a potent restriction factor for HIV (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundEvolutionary genomics and HIV restriction factors
Pyndiah, N., Telenti, A., & Rausell, A. (2015) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000138 · Cited by 13
Manipulation of immunometabolism by HIV—accessories to the crime?
Matheson, N. J., Greenwood, E. J. D., & Lehner, P. J. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.06.014 · Cited by 16
RNA-Associated Early-Stage Antiviral Factor Is a Major Component of Lv2 Restriction
Marno, K. M., O’Sullivan, E., Jones, C. E., Díaz-Delfín, J., Pardieu, C., Sloan, R. D., & McKnight, Á. (2017) · Journal of Virology · doi:10.1128/jvi.01228-16 · Cited by 14
“Further disabling reverse transcription, SAMHD1 depletes the deoxynucleoside triphosphate substrates required (24).”
BackgroundInhibitory Effects of HIV-2 Vpx on Replication of HIV-1
Mahdi, M., Szojka, Z. I., Mótyán, J. A., & Tőzsér, J. (2018) · Journal of Virology · doi:10.1128/jvi.00554-18 · Cited by 13
“Besides playing an important role in the nuclear import of viral DNA in dividing as well as nondividing cells (34, 35), a cardinal function of HIV-2 Vpx is the induction of the proteolytic degradation of the triphosphohydrolase SAM domain- and HD domain-containing protein 1 (SAMHD1) through the E3 ubiquitin ligase com…”
BackgroundMethodDual effect of the broad spectrum kinase inhibitor midostaurin in acute and latent HIV-1 infection
García-Vidal, E., Badía, R., Pujantell, M., Castellví, M., Felip, E., Clotet, B., Riveira‐Muñoz, E., Ballana, E., & Esté, J. A. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2019.05.003 · Cited by 16
Hyeon, S., Lee, M. K., Kim, Y.-E., Lee, G. M., & Ahn, J. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00391 · Cited by 13
“Sterile alpha motif (SAM) and histidine-aspartate (HD) domain-containing protein 1 (SAMHD1) was initially identified as a restriction factor that inhibits HIV-1 infection and shown to be counteracted by the viral Vpx protein through proteasomal degradation (Berger et al., 2011; Hrecka et al., 2011; Laguette et al., 20…”
BackgroundBoo, S. Y., Tan, S. W., Alitheen, N. B., Ho, C. L., Omar, A. R., & Yeap, S. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-75340-x · Cited by 18
Dias, J., Cattin, A., Bendoumou, M., Dutilleul, A., Lodge, R., Goulet, J.-P., Fert, A., Marchand, L. R., Salinas, T. R. W., Yoka, C. D. N., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114414 · Cited by 15
In Vitro HIV Infection Impairs the Capacity of Myeloid Dendritic Cells to Induce Regulatory T Cells
Presicce, P., Moreno‐Fernandez, M. E., Rusie, L. K., Fichtenbaum, C. J., & Chougnet, C. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042802 · Cited by 13
Britto, A. M. A., Amoêdo, N. D., Pezzuto, P., Afonso, A. O., de Martínez, A. M. B., Silveira, J. M., Sion, F. S., Machado, E. S., Soares, M. A., & Giannini, A. L. M. (2013) · AIDS · doi:10.1097/qad.0b013e328361cfbf · Cited by 12
“of host restriction factors [3–7] and viral sensors (TLR and RLR) [8–11].”
BackgroundInhibitory and Stimulatory Effects of IL-32 on HIV-1 Infection
Nasser, H., Takahashi, N., Eltalkhawy, Y. M., Reda, O., Lotfi, S., Nasu, K., Sakuragi, J.-I., & Suzu, S. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200087 · Cited by 13
Sulforaphane Reduces SAMHD1 Phosphorylation To Protect Macrophages from HIV-1 Infection
Sharifi, H. J., Paine, D. N., Fazzari, V. A., Tipple, A. F., Patterson, E., & de Noronha, C. M. C. (2022) · Journal of Virology · doi:10.1128/jvi.01187-22 · Cited by 13
“SIV/HIV-2 Vpx is an established antagonist of SAMHD1, triggering proteosome-dependent SAMHD1 degradation through the CRL4 ubiquitin ligase complex (6, 7, 30).”
BackgroundYang, H., Espada, C. E., Phillips, S. L., Martinez, N., Kenney, A. D., Yount, J. S., Xiong, Y., & Wu, L. J. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104750 · Cited by 17
Snyder, C. M., & Gill, S. I. (2023) · Immunological Reviews · doi:10.1111/imr.13231 · Cited by 13
Ciftci, H. I., Fujino, H., Koga, R., Yamamoto, M., Kawamura, S., Tateishi, H., Iwatani, Y., Otsuka, M., & Fujita, M. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.04.038 · Cited by 12
“This process is induced by the formation of a Cul4-DDB1-DCAF1 E3 ligase complex and the proteasome-dependent degradation of a restriction factor [22– 24], identified as SAMHD1 in 2011 [25,26].”
BackgroundLim, E. S., & Emerman, M. (2011) · Nature · doi:10.1038/474587a · Cited by 17
Goetze, R. W., Kim, D.-H., Schinazi, R. F., & Kim, B. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.793661 · Cited by 16
“Two such mechanisms involve tight control of dNTP biosynthesis by inhibition of ribonucleotide reductase (24) and activation of dNTP hydrolysis by sterile motif and HD domain-containing protein 1 (SAMHD1) (25, 26).”
BackgroundSwanstrom, A. E., Prete, G. Q. D., Deléage, C., Elser, S. E., Lackner, A. A., & Hoxie, J. A. (2017) · Current HIV Research · doi:10.2174/1570162x15666171124123116 · Cited by 13
Effect of induced dNTP pool imbalance on HIV-1 reverse transcription in macrophages
Shepard, C., Xu, J., Holler, J. M., Kim, D., Mansky, L. M., Schinazi, R. F., & Kim, B. (2019) · Retrovirology · doi:10.1186/s12977-019-0491-0 · Cited by 12
Cor-Hosmer, S. K. V., Kim, D., Daly, M. B., Daddacha, W. B., & Kim, B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.486787 · Cited by 12
“A series of recent studies have revealed that SAMHD1, a dNTP triphosphohydrolase, is expressed in myeloid cells, including monocytes, macrophages, and dendritic cells, and that SAMHD1contributes to regulating the lowdNTPpool (10, 11, 17).”
BackgroundVirological characterization of HIV-2 vpx gene mutants in various cell systems
Nomaguchi, M., Doi, N., & Adachi, A. (2014) · Microbes and Infection · doi:10.1016/j.micinf.2014.06.004 · Cited by 12
Species tropism of HIV-1 modulated by viral accessory proteins
Nomaguchi, M., Doi, N., Matsumoto, Y., Sakai, Y., Fujiwara, S., & Adachi, A. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00267 · Cited by 12
“Very recently, SAMHD1 and APOBEC3A have been reported to be myeloid cell-specific restriction factors against HIV-1 counteracted by Vpx (Berger et al., 2011; Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundTargeting Cellular Cofactors in HIV Therapy
Dürr, R., Keppler, O. T., Christ, F., Crespan, E., Garbelli, A., Maga, G., & Dietrich, U. (2014) · Topics in medicinal chemistry · doi:10.1007/7355_2014_45 · Cited by 12
Vellas, C., Martres, D., Réquena, M., Nayrac, M., Collercandy, N., Latour, J., Barange, K., Alric, L., Martin‐Blondel, G., Izopet, J., et al. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae557 · Cited by 14
Post-translational modifications inducing proteasomal degradation to counter HIV-1 infection
Proulx, J. M., Borgmann, K., & Park, I.-W. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198142 · Cited by 12
Differential Inhibition of HIV Replication by the 12 Interferon Alpha Subtypes
Tauzin, A., Ortiz, A. E., Blake, O., Soundaramourty, C., Joly-Beauparlant, C., Nicolas, A., Droit, A., Dutrieux, J., Estaquier, J., & Mammano, F. (2021) · Journal of Virology · doi:10.1128/jvi.02311-20 · Cited by 12
“The restriction factors TRIM5a and SAMHD1 are known to reduce the efficiency of reverse transcription (53, 54).”
BackgroundMechanism by which T7 bacteriophage protein Gp1.2 inhibits Escherichia coli dGTPase
Klemm, B. P., Singh, D., Smith, C., Hsu, A. L., Dillard, L. B., Krahn, J. M., London, R. E., Mueller, G. A., Borgnia, M. J., & Schaaper, R. M. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2123092119 · Cited by 11
“The enzyme is a hexameric homolog of the tetrameric human SAMHD1 (11), a dNTPase that was also implicated as a restriction factor against viruses such as HIV (6).”
BackgroundInfluentialAttenuation of reverse transcriptase facilitates SAMHD1 restriction of HIV-1 in cycling cells
Tsai, M.-H., Caswell, S. J., Morris, E. R., Mann, M. C., Pennell, S., Kelly, G. P., Groom, H. C. T., Taylor, I. A., & Bishop, K. N. (2023) · Retrovirology · doi:10.1186/s12977-023-00620-z · Cited by 11
E3 Ubiquitin Ligases in Gammaherpesviruses and HIV: A Review of Virus Adaptation and Exploitation
Oswald, J., Constantine, M., Adegbuyi, A., Omorogbe, E., Dellomo, A. J., & Ehrlich, E. S. (2023) · Viruses · doi:10.3390/v15091935 · Cited by 13
“Vpx, encoded by HIV-2 and some lineages of SIV, counteracts the activity of SAMHD1 by targeting the restriction factor for proteasomal degradation [175,176,215,221].”
Schüssler, M., Schott, K., Fuchs, N. V., Oo, A., Zahadi, M., Rauch, P., Kim, B., & König, R. (2023) · mBio · doi:10.1128/mbio.02252-23 · Cited by 12
“In addition, SAMHD1 mutants shown to lack dNTPase activity, both in vitro and in cells, lose their restrictive potential when overexpressed in phorbol 12-myristate-13-acetate (PMA)-activated macrophage-like U937 cells (2, 11–13).”
BackgroundResultInfluentialInteractions Between HIV-1 and Innate Immunity in Dendritic Cells
Silvin, A., & Manel, N. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4433-6_7 · Cited by 12
Effects of human SAMHD1 polymorphisms on HIV-1 susceptibility
White, T. E., Brandariz-Núñez, A., Valle‐Casuso, J. C., Knowlton, C., Kim, B., Sawyer, S. L., & Diaz‐Griffero, F. (2014) · Virology · doi:10.1016/j.virol.2014.04.023 · Cited by 13
“As a control, we challenged cells expressing the SAMHD1-HD206AA variant, which does not block HIV-1 infection(Hrecka et al., 2011; Laguette et al., 2011), by using increasing amounts of EIAVGFP.”
BackgroundMethodInfluentialPoeschla, E. M. (2013) · Virology · doi:10.1016/j.virol.2013.03.010 · Cited by 14
“The primate lentiviral accessory protein Vpx, which is normally confined to the HIV-2/SIVsm/SIVrcm/SIVmac lineages, targets SAMHD1 for proteasomal degradation (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundOliva, H., Pacheco, R., Martinez-Navío, J. M., Rodríguez‐García, M., Naranjo‐Gómez, M., Climent, N., Prado, C. E., Gil, C., Plana, M., García, F., et al. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.28 · Cited by 14
Reversing HIV latency via sphingosine-1-phosphate receptor 1 signaling
Duquenne, C., Gimenez, S., Guigues, A., Viala, B., Boulouis, C., Mettling, C., Maurel, D., Campos, N., Doumazane, E., Comps‐Agrar, L., et al. (2017) · AIDS · doi:10.1097/qad.0000000000001649 · Cited by 11
“We neutralized the HIV restriction factor SAMHD1 by exposing these dendritic cells to pseudo viral particles delivering Vpx, and infected them with an R5 strain in presence or absence of FTY720-P.”
MethodInfluentialHani, L., Chaillon, A., Néré, M. L., Ruffin, N., Alameddine, J., Salmona, M., Zaragoza, J.-L. L., Smith, D. M., Schwartz, O., Lelièvre, J., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007868 · Cited by 12
Self-citationLindgren, A. A., Filipowicz, A. R., Hattler, J. B., Kim, S. O., Chung, H. K., Kuroda, M. J., Johnson, E. M., & Kim, W. (2018) · AIDS · doi:10.1097/qad.0000000000001793 · Cited by 11
Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa Cells
Rodríguez-Frandsen, A., Martin‐Sancho, L., Gounder, A. P., Chang, M. W., Liu, W., Jesus, P. D. D., von Recum-Knepper, J., Dutra, M. S., Huffmaster, N. J., Chavarria, M., et al. (2019) · Journal of Virology · doi:10.1128/jvi.01410-19 · Cited by 12
Specific Deubiquitinating Enzymes Promote Host Restriction Factors Against HIV/SIV Viruses
Gao, W., Rui, Y., Li, G., Zhai, C., Su, J., Liu, H., Zheng, W., Zheng, B., Zhang, W., Yang, Y., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.740713 · Cited by 11
“Vpx proteins of HIV-2Rod and certain SIVs overcome the antiviral function of SAMHD1 in myeloid cells by inducing its polyubiquitination and degradation (19, 20).”
BackgroundMethodInfluentialSAMHD1 Mutations and Expression in Mantle Cell Lymphoma Patients
Wang, T., Yue, W., Tang, G., Ye, M., Yu, J., Liu, B., Jiao, L., Liu, X., Yin, S., Chen, J., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.763151 · Cited by 11
Genotoxic stress signalling as a driver of macrophage diversity
Kasapi, A., & Triantafyllopoulou, A. (2022) · Cell Stress · doi:10.15698/cst2022.03.265 · Cited by 11
“The virus counteracts this restriction by expressing Vpx, a protein that induces proteasomal degradation of SAMHD1 [64].”
BackgroundThe TRIMCyp genotype in four species of macaques in China
Yu, C.-Q., Na, L., Lv, X.-L., Liu, J.-D., Liu, X.-M., Ji, F., Zheng, Y., Du, H.-L., Kong, X.-G., & Zhou, J.-H. (2012) · Immunogenetics · doi:10.1007/s00251-012-0670-9 · Cited by 13
“2008), and the recently reported SAM domain HD domain-containing protein 1 (SAMHD1) (Hrecka et al. 2011; Laguette et al. 2011).”
BackgroundWang, W., Wang, J., Qu, M., Li, X., Zhang, J., Zhang, H., Wu, J., Yu, B., Wu, H., Kong, W., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138190 · Cited by 11
Genetic variation in Trex1 affects HIV-1 disease progression
Booiman, T., Setiawan, L. C., & Kootstra, N. A. (2014) · AIDS · doi:10.1097/qad.0000000000000436 · Cited by 11
“0269-9370 Q 2014 Wolters Kluwer Hea described explaining how HIV-1 evades innate detection [3,4].”
BackgroundTyrosine Kinase Inhibition: a New Perspective in the Fight against HIV
Rodríguez-Mora, S., Spivak, A. M., Szaniawski, M. A., López‐Huertas, M. R., Alcamí, J., Planelles, V., & Coiras, M. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00462-5 · Cited by 11
Rausch, J. W., & Grice, S. F. J. L. (2019) · Current HIV Research · doi:10.2174/1570162x18666191231105438 · Cited by 13
Reverse Transcription of Retroviruses and LTR Retrotransposons
Hughes, S. H. (2015) · ASM Press eBooks · doi:10.1128/9781555819217.ch46 · Cited by 13
Restriction of Retroviral Infection of Macrophages
Sharkey, M. E. (2013) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-37765-5_4 · Cited by 12
CRL4-DCAF1 Ubiquitin Ligase Dependent Functions of HIV Viral Protein R and Viral Protein X
Dobransky, A., Root, M., Hafner, N., Marcum, M., & Sharifi, H. J. (2024) · Viruses · doi:10.3390/v16081313 · Cited by 13
“SAM and HD domain-containing protein 1 (SAMHD1) was identified as the major restriction factor limiting HIV replication in myeloid lineage cells that is countered by Vpx [199,204].”
BackgroundFinetuning Type I Interferon Signaling to Enhance T Cell Immunity in HIV Infection
Mu, W., Kedia, N., & Zhen, A. (2025) · Viruses · doi:10.3390/v17060774 · Cited by 11
“Studies have demonstrated that SAMHD1-mediated dNTP depletion, induced by type I IFNs, significantly limits HIV replication in macrophages and dendritic cells [49,50].”
Ferguson, D., Mattiuzzo, G., Ham, C., Stebbings, R., Li, B., Rose, N. J., Mee, E. T., Smith, D., Page, M., Cranage, M. P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104390 · Cited by 10
“Vpx antagonises the restriction factor SAMHD1 and may allow replication in myeloid lineage cells that are not permissive to HIV-1 in vivo [40,41,59].”
BackgroundInfluentialHIV Impairment of Immune Responses in Dendritic Cells
Ahmed, Z., Czubala, M. A., Blanchet, F. P., & Piguet, V. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4433-6_8 · Cited by 11
Nchioua, R., Kmieć, D., Gaba, A., Stürzel, C. M., Follack, T. B., Patrick, S., Kirmaier, A., Johnson, W. E., Hahn, B. H., Chelico, L., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00808-21 · Cited by 10
“For example, the SIVsmm Env protein is active against human tetherin (9, 10), and the SIVsmm Vpx protein counteracts the human orthologue of SAMHD1 (11) as well as the human HUSH complex (12).”
BackgroundPhage defense origin of animal immunity
Morehouse, B. R. (2023) · Current Opinion in Microbiology · doi:10.1016/j.mib.2023.102295 · Cited by 10
Understanding the molecular manipulation of DCAF1 by the lentiviral accessory proteins Vpr and Vpx
Cassiday, P. A., DePaula-Silva, A. B., Chumley, J., Ward, J. P., Barker, E., & Planelles, V. (2014) · Virology · doi:10.1016/j.virol.2014.11.024 · Cited by 14
“Although Vpr and Vpx share a high degree of homology they are known to induce markedly different effects in host cell biology through the recruitment of different substrates to CRL4.”
InfluentialA new activity for SAMHD1 in HIV restriction
Yang, Z., & Greene, W. C. (2014) · Nature Medicine · doi:10.1038/nm.3657 · Cited by 12
MCPIP1/regnase-I inhibits simian immunodeficiency virus and is not counteracted by Vpx
Li, H., & Wang, T. T. (2016) · Journal of General Virology · doi:10.1099/jgv.0.000482 · Cited by 11
Farley, D. C., McCloskey, L., Thorne, B. A., Tareen, S. U., Nicolai, C. J., Campbell, D. J., Bannister, R., Stewart, H. J., Pearson, L. J., Moyer, B., et al. (2015) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2015.17 · Cited by 11
Molecular dynamics investigation of a redox switch in the anti‐HIV protein SAMHD1
Patra, K. K., Bhattacharya, A., & Bhattacharya, S. (2019) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25701 · Cited by 10
Yap, M. W., Young, G. R., Varnaitė, R., Morand, S., & Stoye, J. P. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008471 · Cited by 10
“Some of these, like TRIM5α [3], APOBEC3G [4], and SAMHD1 [5, 6], act at or before reverse transcription, while others, such as tetherin [7] and SERINC5 [8, 9], inhibit viral budding or fusion.”
BackgroundEvolutionary Genetics of Mycobacterium Tuberculosis and HIV-1: “The Tortoise and the Hare”
Pereira, A. M. M. B., Magalhães, C., Araújo, P. M. M., & Osório, N. S. (2021) · Microorganisms · doi:10.3390/microorganisms9010147 · Cited by 14
Bowen, N. E., Temple, J. E., Shepard, C., Oo, A., Arizaga, F., Kapoor-Vazirani, P., Persaud, M., Yu, C. H., Kim, D., Schinazi, R. F., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101170 · Cited by 12
“In addition, SAMHD1 dNTPase activity restricts HIV-1 infection in nondividing myeloid cells (10, 11).”
BackgroundMethodInfluentialSTRIPE3, encoding a human dNTPase SAMHD1 homolog, regulates chloroplast development in rice
Wang, H., Tu, R., Ruan, Z., Wu, D., Peng, Z., Zhou, X., Liu, Q., Wu, W., Cao, L., Cheng, S., et al. (2022) · Plant Science · doi:10.1016/j.plantsci.2022.111395 · Cited by 10
Shi, H., Duan, J., Wang, J., Li, H., Wu, Z., Wang, S., Wu, X., & Lu, M. (2022) · Nutrients · doi:10.3390/nu14224935 · Cited by 10
“SAMHD1, a dNTP triphosphohydrolase (dNTPase), can hydrolyze intracellular dNTPs, thereby reducing viral reverse transcription and cDNA synthesis [43,44].”
BackgroundSpatial resolution of HIV-1 post-entry steps in resting CD4 T cells
Ananth, S., Ambiel, I., Schifferdecker, S., Müller, T. G., Wratil, P. R., Mejías‐Pérez, E., Kräusslich, H., Müller, B., Keppler, O. T., & Fackler, O. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113941 · Cited by 11
Hou, J., Zhang, Q., Liu, Z., Wang, S., Li, D., Liu, C., Liu, Y., & Shao, Y. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1082692 · Cited by 10
“Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Segeral E, Yatim A, Emiliani S, Schwartz O, Benkirane M. SAMHD1 is the dendriticand myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011; 474:654-7; PMID:21613998; http://dx.doi.org/10.1038/ nature10117 33.”
BackgroundInfluentialThe Innate Immune Response to HIV-1: To Sense or Not to Sense
Landau, N. R. (2014) · DNA and Cell Biology · doi:10.1089/dna.2014.2378 · Cited by 10
“The response required the addition of the lentiviral accessory protein Vpx to the cells as a means of overcoming the SAMHD1-mediated block to reverse transcription (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundModulation of LINE-1 retrotransposition by a human SAMHD1 polymorphism
White, T. E., Brandariz-Núñez, A., Han, K., Sawyer, S. L., Kim, B., & Diaz‐Griffero, F. (2016) · Virology Reports · doi:10.1016/j.virep.2016.06.001 · Cited by 12
“The ability of SAMHD1 to block HIV-1 infection requires SAMHD1’s enzymatic activity (Laguette et al., 2011; Lahouassa et al., 2012; Seamon et al., 2015).”
BackgroundMethodInfluentialHost SAMHD1 protein restricts endogenous reverse transcription of HIV-1 in nondividing macrophages
Mahboubi, B., Gavegnano, C., Kim, D., Schinazi, R. F., & Kim, B. (2018) · Retrovirology · doi:10.1186/s12977-018-0452-z · Cited by 10
Dual roles of SAMHD1 in tumor development and chemoresistance to anticancer drugs (Review)
Chen, Z., Hu, J., Ying, S., & Xu, A. (2021) · Oncology Letters · doi:10.3892/ol.2021.12712 · Cited by 11
“Mass spectrometry results have demonstrated that SAMHD1 inter‐ acts with Vpx, which induces the degradation of SAMHD1 via the ubiquitin‐ proteasome pathway (5).”
BackgroundThe SAMHD1 knockout mouse model: in vivo veritas?
Roesch, F., & Schwartz, O. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.190 · Cited by 10
“Finally, the dNTP hydrolase SAMHD1 acts to deplete the intracellular pool of nucleotides available for viral DNA synthesis by reverse transcriptase (RT) (Hrecka et al , 2011; Laguette et al , 2011; Lahouassa et al , 2012).”
Self-citationGuo, H., Zhang, N., Shen, S., Yu, X., & Wei, W. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.04.085 · Cited by 10
Tactics used by HIV-1 to evade host innate, adaptive, and intrinsic immunities
Lu, L. U., Yu, F., Du, L., Wei, X. U., & Jiang, S. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20122551 · Cited by 17
No evidence of human genome integration of SARS-CoV-2 found by long-read DNA sequencingPreprint
Smits, N., Rasmussen, J., Bodea, G. O., Amarilla, A. A., Gerdes, P., Sanchez-Luque, F. J., Ajjikuttira, P., Modhiran, N., Liang, B., Faivre, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.28.446065 · Cited by 10
Rangaraj, S., Agarwal, A., & Banerjee, S. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00870 · Cited by 10
dNTP depletion and beyond: the multifaceted nature of SAMHD1-mediated viral restriction
Cheung, P. H., Yang, H., & Wu, L. J. (2025) · Journal of Virology · doi:10.1128/jvi.00302-25 · Cited by 12
“In terms of antiviral functions, it was observed that destroying the dNTPase active sites of SAMHD1 by mutating H206 and D207 abolished SAMHD1 restriction on HIV-1 infection in non-dividing myeloid cells (21, 22).”
Expression of intron-containing HIV-1 RNA induces NLRP1 inflammasome activation in myeloid cells
Jalloh, S., Hughes, I. A., Akiyama, H., Gojanovich, A. D., Quiñones-Molina, A. A., Yang, M., Henderson, A. J., Mostoslavsky, G., & Gummuluru, S. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003320 · Cited by 10
iPS cell–derived model to study the interaction between tissue macrophage and HIV-1
Eltalkhawy, Y. M., Takahashi, N., Ariumi, Y., Shimizu, J., Miyazaki, K., Senju, S., & Suzu, S. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad024 · Cited by 10
Zhang, S. M., Paulin, C. B. J., Shu, H., Yagüe-Capilla, M., Michel, M., Marttila, P., Ortis, F., Bwanika, H. C., Dirks, C., Vekatram, R. P., et al. (2024) · iScience · doi:10.1016/j.isci.2024.108907 · Cited by 10
“SAMHD1 was also identified as a human immunodeficiency virus type-1 (HIV-1) restriction factor in myeloid cells 24,25 and resting T cells.”
BackgroundJäger, N., Ayyub, S. A., Peske, F., Liedtke, D., Bohne, J., Hoffmann, M., Rodnina, M. V., & Pöhlmann, S. (2024) · Viruses · doi:10.3390/v16040583 · Cited by 9
“…factors have been identified that inhibit human immunodeficiency virus (HIV) infection, including APOBEC3G [2], BST2/tetherin and SAMHD1 [3], which block discrete steps of viral replication, such as reverse transcription (APOBEC3G and SAMHD1) or the release of progeny particles from…”
BackgroundPlatform-directed allostery and quaternary structure dynamics of SAMHD1 catalysis
Acton, O. J., Sheppard, D., Kunzelmann, S., Caswell, S. J., Nans, A., Burgess, A., Kelly, G. P., Morris, E. R., Rosenthal, P. B., & Taylor, I. A. (2024) · Nature Communications · doi:10.1038/s41467-024-48237-w · Cited by 9
“In HIV-2 and related simian viruses, this restriction is overcome by the lentiviral accessory protein Vpx that targets human SAMHD1 for degradation by the proteasomal pathway 9,11,12 through interactions with the cullin-4 ligase substrate adaptor DCAF1 17 – 19 .”
BackgroundInterferon-Stimulated Genes that Target Retrovirus Translation
Jäger, N., Pöhlmann, S., Rodnina, M. V., & Ayyub, S. A. (2024) · Viruses · doi:10.3390/v16060933 · Cited by 9
Kelly, S. H., Nightingale, S., Gupta, R. K., & Collier, D. A. (2025) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed10020045 · Cited by 10
“Myeloid cells are intrinsically relatively resistant to productive infection due to the restriction factor sterile alpha motif domain and histidine–aspartic domain-containing protein 1 (SAMHD1) that blocks reverse transcription by depletion of deoxynucleotide triphosphate (dNTP) [66,67].”
Daddacha, W. B., Noble, E., Nguyen, L. A., Kennedy, E. M., & Kim, B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.458398 · Cited by 11
“Recently, we and others reported that the low dNTP pool in macrophages is partially due to active hydrolysis of cellular dNTPs by SAMHD1, a cellular dNTP triphosphohydrolase (5, 6).”
BackgroundSAMHD1 prive le VIH des nucléotides essentiels à la synthèse d’ADN viral
Lahouassa, H., Dragin, L., Transy, C., & Margottin-Goguet, F. (2012) · médecine/sciences · doi:10.1051/medsci/20122811002 · Cited by 9
“(➜) [10], SAMHD1 [SAM domain and HD domain 1] a été découverte en 2011 comme une protéine cellulaire bloquant l’infection virale dans les macrophages et les cellules dendritiques [1, 2].”
BackgroundHIV and innate immunity – a genomics perspective
Rausell, A., McLaren, P. J., & Telenti, A. (2013) · F1000Prime Reports · doi:10.12703/p5-29 · Cited by 9
“Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M, Srivastava S, Florens L, Washburn MP, Skowronski J: Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein.”
BackgroundInfluential
Metadata
- Authors
- Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Laguette, Nadine
- Benkirane, Monsef
- ORCID
- Venue
- Nature
- Published
- 2011-05-25
- Volume
- 474
- Issue
- 7353
- Pages
- 654-657
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3595993
- OpenAlex
- W2069554621
- Cited by
- 1,511
- References
- 27
- Citations by year
- 2026: 45 · 2025: 60 · 2024: 67 · 2023: 67 · 2022: 84 · 2021: 72 · 2020: 82 · 2019: 113 · 2018: 113 · 2017: 109 · 2016: 114 · 2015: 118 · 2014: 134 · 2013: 159 · 2012: 131
- FWCI
- 58.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- SAMHD1, HIV-1 restriction factors, Vpx, dendritic cells, myeloid cells, Aicardi-Goutières syndrome, proteasomal degradation, HIV-1 replication, viral DNA accumulation, phosphohydrolase activity, interferon response, HIV-2, simian immunodeficiency virus
- MeSH terms
- SAM Domain and HD Domain-Containing Protein 1, Cell Line, Dendritic Cells, DNA, Viral, HeLa Cells, Humans, Virus Replication, HIV-1, HIV Infections, U937 Cells, Monomeric GTP-Binding Proteins, Gene Silencing, Myeloid Cells, Proteasome Endopeptidase Complex, Viral Regulatory and Accessory Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.